These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 1516063

  • 41. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R.
    Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681
    [Abstract] [Full Text] [Related]

  • 42. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro.
    Skov KA, Farrell NP, Adomat H.
    Radiat Res; 1987 Nov 15; 112(2):273-82. PubMed ID: 3685256
    [Abstract] [Full Text] [Related]

  • 43. Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4'-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes.
    Wheate NJ, Cullinane C, Webster LK, Collins JG.
    Anticancer Drug Des; 2001 Nov 15; 16(2-3):91-8. PubMed ID: 11962517
    [Abstract] [Full Text] [Related]

  • 44. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Skov KA, Adomat H, Chaplin DJ, Farrell NP.
    Anticancer Drug Des; 1990 Feb 15; 5(1):121-8. PubMed ID: 2156514
    [Abstract] [Full Text] [Related]

  • 45. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.
    Kelland LR, Murrer BA, Abel G, Giandomenico CM, Mistry P, Harrap KR.
    Cancer Res; 1992 Feb 15; 52(4):822-8. PubMed ID: 1737343
    [Abstract] [Full Text] [Related]

  • 46. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF, Bodtke A, Bednarski PJ.
    Dalton Trans; 2011 May 21; 40(19):5342-51. PubMed ID: 21461431
    [Abstract] [Full Text] [Related]

  • 47. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR, Barnard CF, Evans IG, Murrer BA, Theobald BR, Wyer SB, Goddard PM, Jones M, Valenti M, Bryant A.
    J Med Chem; 1995 Aug 04; 38(16):3016-24. PubMed ID: 7636864
    [Abstract] [Full Text] [Related]

  • 48. Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes.
    Farrell N, Qu Y, Hacker MP.
    J Med Chem; 1990 Aug 04; 33(8):2179-84. PubMed ID: 2374143
    [Abstract] [Full Text] [Related]

  • 49. Ligand effects on platinum binding to DNA. A comparison of DNA binding properties for cis- and trans-[PtCl2(amine)2] (amine = NH3, pyridine).
    Zou Y, Van Houten B, Farrell N.
    Biochemistry; 1993 Sep 21; 32(37):9632-8. PubMed ID: 8373767
    [Abstract] [Full Text] [Related]

  • 50. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R, Khokhar AR.
    Cancer Res; 1992 Nov 15; 52(22):6341-7. PubMed ID: 1423280
    [Abstract] [Full Text] [Related]

  • 51. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR, Barnard CF, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR.
    Cancer Res; 1994 Nov 01; 54(21):5618-22. PubMed ID: 7923207
    [Abstract] [Full Text] [Related]

  • 52. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
    Zákovská A, Nováková O, Balcarová Z, Bierbach U, Farrell N, Brabec V.
    Eur J Biochem; 1998 Jun 15; 254(3):547-57. PubMed ID: 9688265
    [Abstract] [Full Text] [Related]

  • 53. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
    Benedetti BT, Quintal S, Farrell NP.
    Dalton Trans; 2011 Nov 07; 40(41):10983-8. PubMed ID: 21918760
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
    Kido Y, Khokhar AR, Siddik ZH.
    Anticancer Drugs; 1993 Apr 07; 4(2):251-8. PubMed ID: 8490203
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
    Kraker AJ, Hoeschele JD, Elliott WL, Showalter HD, Sercel AD, Farrell NP.
    J Med Chem; 1992 Nov 27; 35(24):4526-32. PubMed ID: 1335074
    [Abstract] [Full Text] [Related]

  • 59. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD, Showalter HD, Kraker AJ, Elliott WL, Roberts BJ, Kampf JW.
    J Med Chem; 1994 Aug 19; 37(17):2630-6. PubMed ID: 8064793
    [Abstract] [Full Text] [Related]

  • 60. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M, Novakova O, Stepankova J, Novohradsky V, Gibson D, Kasparkova J, Brabec V.
    J Inorg Biochem; 2013 Sep 19; 126():46-54. PubMed ID: 23770803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.